Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study

BACKGROUND: As recommended in the current prescribing information, rituximab infusions in patients with rheumatoid arthritis (RA) take 4.25 hours for the first infusion and 3.25 hours for subsequent infusions, which is a burden on patients and the health care system. We therefore evaluated the safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Pritchard, Charles H, Greenwald, Maria W, Kremer, Joel M, Gaylis, Norman B, Rigby, William, Zlotnick, Steve, Chung, Carol, Jaber, Birgit, Reiss, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035685/
https://www.ncbi.nlm.nih.gov/pubmed/24884454
http://dx.doi.org/10.1186/1471-2474-15-177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035685/
https://www.ncbi.nlm.nih.gov/pubmed/24884454
http://dx.doi.org/10.1186/1471-2474-15-177

Ejemplares similares